203 related articles for article (PubMed ID: 17634297)
1. Molecular epidemiological and antibiotic susceptibility characterization of Brucella isolates from humans in Sicily, Italy.
Marianelli C; Graziani C; Santangelo C; Xibilia MT; Imbriani A; Amato R; Neri D; Cuccia M; Rinnone S; Di Marco V; Ciuchini F
J Clin Microbiol; 2007 Sep; 45(9):2923-8. PubMed ID: 17634297
[TBL] [Abstract][Full Text] [Related]
2. Biotypes and antimicrobial susceptibilities of Brucella isolates.
Bodur H; Balaban N; Aksaray S; Yetener V; Akinci E; Colpan A; Erbay A
Scand J Infect Dis; 2003; 35(5):337-8. PubMed ID: 12875523
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Brucella MLVA typing for human brucellosis.
Al Dahouk S; Flèche PL; Nöckler K; Jacques I; Grayon M; Scholz HC; Tomaso H; Vergnaud G; Neubauer H
J Microbiol Methods; 2007 Apr; 69(1):137-45. PubMed ID: 17261338
[TBL] [Abstract][Full Text] [Related]
4. A new variant of Brucella melitensis.
Lucero NE; Ayala SM; Escobar GI; Grayon M; Jacques I
Clin Microbiol Infect; 2006 Jun; 12(6):593-6. PubMed ID: 16700714
[TBL] [Abstract][Full Text] [Related]
5. In vitro susceptibilities of Brucella melitensis isolates to eleven antibiotics.
Turkmani A; Ioannidis A; Christidou A; Psaroulaki A; Loukaides F; Tselentis Y
Ann Clin Microbiol Antimicrob; 2006 Oct; 5():24. PubMed ID: 17014707
[TBL] [Abstract][Full Text] [Related]
6. Brucella 'HOOF-Prints': strain typing by multi-locus analysis of variable number tandem repeats (VNTRs).
Bricker BJ; Ewalt DR; Halling SM
BMC Microbiol; 2003 Jul; 3():15. PubMed ID: 12857351
[TBL] [Abstract][Full Text] [Related]
7. In vitro antimicrobial susceptibility of Brucella species.
Baykam N; Esener H; Ergönül O; Eren S; Celikbas AK; Dokuzoguz B
Int J Antimicrob Agents; 2004 Apr; 23(4):405-7. PubMed ID: 15081093
[TBL] [Abstract][Full Text] [Related]
8. Identification of Brucella species isolated from proven brucellosis patients in Izmir, Turkey.
Köse S; Kiliç S; Ozbel Y
J Basic Microbiol; 2005; 45(4):323-7. PubMed ID: 16028204
[TBL] [Abstract][Full Text] [Related]
9. Actual antibiotic resistance pattern of Brucella melitensis in central Anatolia. An update from an endemic region.
Tanyel E; Coban AY; Koruk ST; Simsek H; Hepsert S; Cirit OS; Tulek N
Saudi Med J; 2007 Aug; 28(8):1239-42. PubMed ID: 17676210
[TBL] [Abstract][Full Text] [Related]
10. Classification of Brucella spp. isolated from marine mammals by DNA polymorphism at the omp2 locus.
Cloeckaert A; Verger JM; Grayon M; Paquet JY; Garin-Bastuji B; Foster G; Godfroid J
Microbes Infect; 2001 Jul; 3(9):729-38. PubMed ID: 11489421
[TBL] [Abstract][Full Text] [Related]
11. Brucella microti sp. nov., isolated from the common vole Microtus arvalis.
Scholz HC; Hubalek Z; Sedlácek I; Vergnaud G; Tomaso H; Al Dahouk S; Melzer F; Kämpfer P; Neubauer H; Cloeckaert A; Maquart M; Zygmunt MS; Whatmore AM; Falsen E; Bahn P; Göllner C; Pfeffer M; Huber B; Busse HJ; Nöckler K
Int J Syst Evol Microbiol; 2008 Feb; 58(Pt 2):375-82. PubMed ID: 18218934
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial susceptibility of
Shevtsov A; Syzdykov M; Kuznetsov A; Shustov A; Shevtsova E; Berdimuratova K; Mukanov K; Ramankulov Y
Antimicrob Resist Infect Control; 2017; 6():130. PubMed ID: 29299304
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial susceptibilities of Brucella isolates from various clinical specimens.
Bayram Y; Korkoca H; Aypak C; Parlak M; Cikman A; Kilic S; Berktas M
Int J Med Sci; 2011 Mar; 8(3):198-202. PubMed ID: 21448305
[TBL] [Abstract][Full Text] [Related]
14. Molecular, antigenic, and functional analyses of Omp2b porin size variants of Brucella spp.
Paquet JY; Diaz MA; Genevrois S; Grayon M; Verger JM; de Bolle X; Lakey JH; Letesson JJ; Cloeckaert A
J Bacteriol; 2001 Aug; 183(16):4839-47. PubMed ID: 11466287
[TBL] [Abstract][Full Text] [Related]
15. Identification and determination of antibiotic susceptibilities of Brucella strains isolated from patients in van, Turkey by conventional and molecular methods.
Parlak M; Güdücüoğlu H; Bayram Y; Çıkman A; Aypak C; Kılıç S; Berktaş M
Int J Med Sci; 2013; 10(10):1406-11. PubMed ID: 23983603
[TBL] [Abstract][Full Text] [Related]
16. Genetic bases of the rifampin resistance phenotype in Brucella spp.
Marianelli C; Ciuchini F; Tarantino M; Pasquali P; Adone R
J Clin Microbiol; 2004 Dec; 42(12):5439-43. PubMed ID: 15583262
[TBL] [Abstract][Full Text] [Related]
17. Synergy tests by E test and checkerboard methods of antimicrobial combinations against Brucella melitensis.
Orhan G; Bayram A; Zer Y; Balci I
J Clin Microbiol; 2005 Jan; 43(1):140-3. PubMed ID: 15634962
[TBL] [Abstract][Full Text] [Related]
18. Identification of the Brucella melitensis vaccine strain Rev.1 in animals and humans in Israel by PCR analysis of the PstI site polymorphism of its omp2 gene.
Bardenstein S; Mandelboim M; Ficht TA; Baum M; Banai M
J Clin Microbiol; 2002 Apr; 40(4):1475-80. PubMed ID: 11923376
[TBL] [Abstract][Full Text] [Related]
19. Evaluation and selection of tandem repeat loci for a Brucella MLVA typing assay.
Le Flèche P; Jacques I; Grayon M; Al Dahouk S; Bouchon P; Denoeud F; Nöckler K; Neubauer H; Guilloteau LA; Vergnaud G
BMC Microbiol; 2006 Feb; 6():9. PubMed ID: 16469109
[TBL] [Abstract][Full Text] [Related]
20. Intrinsic and selected resistance to antibiotics binding the ribosome: analyses of Brucella 23S rrn, L4, L22, EF-Tu1, EF-Tu2, efflux and phylogenetic implications.
Halling SM; Jensen AE
BMC Microbiol; 2006 Oct; 6():84. PubMed ID: 17014718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
